DE69333352D1 - Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren - Google Patents

Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren

Info

Publication number
DE69333352D1
DE69333352D1 DE69333352T DE69333352T DE69333352D1 DE 69333352 D1 DE69333352 D1 DE 69333352D1 DE 69333352 T DE69333352 T DE 69333352T DE 69333352 T DE69333352 T DE 69333352T DE 69333352 D1 DE69333352 D1 DE 69333352D1
Authority
DE
Germany
Prior art keywords
human
androstanteroids
methods
change
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333352T
Other languages
English (en)
Other versions
DE69333352T2 (de
Inventor
David L Berliner
Nathan William Adams
Clive L Jennings-White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pherin Corp
Original Assignee
Pherin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Corp filed Critical Pherin Corp
Application granted granted Critical
Publication of DE69333352D1 publication Critical patent/DE69333352D1/de
Publication of DE69333352T2 publication Critical patent/DE69333352T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
DE69333352T 1993-06-15 1993-09-28 Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren Expired - Lifetime DE69333352T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7735993A 1993-06-15 1993-06-15
US77359 1993-06-15
PCT/US1993/009349 WO1994028904A1 (en) 1993-06-15 1993-09-28 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods

Publications (2)

Publication Number Publication Date
DE69333352D1 true DE69333352D1 (de) 2004-01-22
DE69333352T2 DE69333352T2 (de) 2004-07-22

Family

ID=22137596

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333352T Expired - Lifetime DE69333352T2 (de) 1993-06-15 1993-09-28 Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren

Country Status (14)

Country Link
EP (2) EP0711169B1 (de)
JP (1) JP3705806B2 (de)
AT (1) ATE255898T1 (de)
BG (1) BG63452B1 (de)
BR (1) BR9307867A (de)
CA (1) CA2165325A1 (de)
DE (1) DE69333352T2 (de)
ES (1) ES2210243T3 (de)
FI (1) FI956029A (de)
HU (1) HUT74172A (de)
NO (1) NO309926B1 (de)
NZ (1) NZ257218A (de)
PL (1) PL183582B1 (de)
WO (1) WO1994028904A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
EP0858505B1 (de) * 1995-10-19 2004-12-29 The Trustees Of Columbia University In The City Of New York Klonierung von pheromon rezeptoren aus vertebraten und deren verwendungen
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
ES2273374T3 (es) * 1996-07-23 2007-05-01 Pherin Pharmaceuticals, Inc. Esteroides como estimuladores neuroquimicos del ovn para aliviar los sintomas de pms.
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
US6544971B1 (en) * 2000-02-04 2003-04-08 Pherin Pharmaceuticals, Inc. Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
US6919337B2 (en) 2000-04-07 2005-07-19 Novartis, Ag 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
US7019136B2 (en) 2000-04-07 2006-03-28 Novartis, Ag 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
EP1234540B1 (de) * 2000-07-05 2007-03-21 Matsushita Electric Industrial Co., Ltd. Gerät zur analyse
US10322138B2 (en) 2012-12-28 2019-06-18 Pherin Pharmaceuticals, Inc. Treatment of depressive disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB765509A (en) * 1954-02-04 1957-01-09 Pfizer & Co C Improvements in or relating to steroids and the preparation thereof
FR7725M (de) * 1967-06-22 1970-03-02
GB1267514A (en) * 1968-07-23 1972-03-22 Nat Res Dev Improvements relating to artificial insemination of pigs
DE2345376A1 (de) * 1973-09-06 1975-03-20 Schering Ag Pharmazeutische zubereitung ii
GB1550343A (en) * 1975-07-16 1979-08-15 Gist Brocades Nv Androstane derivatives
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US5155045A (en) * 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
DD251077A1 (de) * 1986-07-21 1987-11-04 Adw Ddr Mittel zur anregung der brunstreaktion bei schweinen
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
FR2622194B1 (fr) * 1987-10-27 1990-03-23 Theramex Laboratoire Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
DK0614463T3 (da) * 1991-11-22 2003-03-31 Alcon Lab Inc Angiostatiske steroider
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones

Also Published As

Publication number Publication date
BG100286A (bg) 1997-02-28
NO955085D0 (no) 1995-12-14
CA2165325A1 (en) 1994-12-22
JP3705806B2 (ja) 2005-10-12
EP1340502A2 (de) 2003-09-03
BR9307867A (pt) 1996-07-30
FI956029A (fi) 1996-02-14
DE69333352T2 (de) 2004-07-22
ATE255898T1 (de) 2003-12-15
JPH09501409A (ja) 1997-02-10
EP0711169A4 (de) 2000-05-31
AU691474B2 (en) 1998-05-21
HU9503578D0 (en) 1996-02-28
NO309926B1 (no) 2001-04-23
EP1340502A3 (de) 2004-01-21
EP0711169A1 (de) 1996-05-15
AU5350494A (en) 1995-01-03
NZ257218A (en) 1998-07-28
PL183582B1 (pl) 2002-06-28
WO1994028904A1 (en) 1994-12-22
ES2210243T3 (es) 2004-07-01
BG63452B1 (bg) 2002-02-28
HUT74172A (en) 1996-11-28
EP0711169B1 (de) 2003-12-10
PL312279A1 (en) 1996-04-15
NO955085L (no) 1996-02-14
FI956029A0 (fi) 1995-12-14

Similar Documents

Publication Publication Date Title
CA2223397A1 (en) Novel nor-pregnanes for inducing hypothalamic effects
DE69333352D1 (de) Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren
DE69033538D1 (de) Verfahren zur Herstellung der 1,2-Doppelbindung von 4-aza-Steroiden und kristallinen Proscor(R) und pharmazeutische Präparate davon
NZ234051A (en) Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
MD1920F2 (ro) Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer
ATE253365T1 (de) Estrensteroide als neurochemische initiatoren einer veränderung der hypothalmusfunktion beim menschen und verwandte pharmazeutische präparate
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
AU3963797A (en) Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
DE69631770D1 (de) Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
TW289730B (en) Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids
BR9816142A (pt) Esteróides de 19-nor-colano como iniciadores neuroquìmicos de mudança na função hipotalâmica humana
ES2165382T3 (es) Agentes antiateroescleroticos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition